3–5 Sept 2024
Switzerland
Europe/Zurich timezone

Preclinical Development of 161Tb-based Radiopharmaceuticals for Radioligand Therapy

Not scheduled
20m
Paul Scherrer Institut (Switzerland)

Paul Scherrer Institut

Switzerland

Forschungsstrasse 111 5232 Villigen

Speaker

Dr Cristina Müller (PSI)

Presentation materials